{"id":"https://openalex.org/W4416638352","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3691","title":"Assessing Exacerbation History and Bronchiectasis Management in the US Bronchiectasis and NTM Research Registry (BRR)","display_name":"Assessing Exacerbation History and Bronchiectasis Management in the US Bronchiectasis and NTM Research Registry (BRR)","alternate_titles":[],"publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416638352","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3691"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa3691","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3691","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa3691","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epidemiology","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4416638352"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Engin L","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Engin L","raw_affiliation_strings":["1Early Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Early Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002862532","display_name":"Claudia S. Cabrera","orcid":"https://orcid.org/0000-0003-2778-1604","observed_orcids":["https://orcid.org/0000-0003-2778-1604"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Claudia Cabrera","raw_affiliation_strings":["2Evidence, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca,, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Evidence, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca,, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103258710","display_name":"Rod Hughes","orcid":"https://orcid.org/0009-0006-1200-5580","observed_orcids":["https://orcid.org/0009-0006-1200-5580"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rod Hughes","raw_affiliation_strings":["3Early Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Early Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033934919","display_name":"Fred Reid","orcid":"https://orcid.org/0009-0009-8708-940X","observed_orcids":["https://orcid.org/0009-0009-8708-940X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fred Reid","raw_affiliation_strings":["3Early Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Early Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078245669","display_name":"Gabriel Abreu","orcid":"https://orcid.org/0000-0001-7926-2385","observed_orcids":["https://orcid.org/0000-0001-7926-2385"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Gabriel Abreu","raw_affiliation_strings":["4Early biometrics, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Early biometrics, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067770078","display_name":"Wayne Brailsford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Wayne Brailsford","raw_affiliation_strings":["5Early projects, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Early projects, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060498946","display_name":"Amanda E. Brunton","orcid":"https://orcid.org/0000-0003-4061-5870","observed_orcids":["https://orcid.org/0000-0003-4061-5870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Brunton","raw_affiliation_strings":["6COPD Foundation, Washington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6COPD Foundation, Washington, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107771576","display_name":"George Solomon","orcid":"https://orcid.org/0009-0000-6850-385X","observed_orcids":["https://orcid.org/0009-0000-6850-385X"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Solomon","raw_affiliation_strings":["7University of Alabama, Division of Pulmonary, Allergy, and Critical Care Medicine, Birmingham, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7University of Alabama, Division of Pulmonary, Allergy, and Critical Care Medicine, Birmingham, United States","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079571245","display_name":"Emily M. Henkle","orcid":"https://orcid.org/0000-0002-5190-9383","observed_orcids":["https://orcid.org/0000-0002-5190-9383"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Henkle","raw_affiliation_strings":["8Oregon Health & Science University, OHSU-PSU School of Public Health, Portland, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Oregon Health & Science University, OHSU-PSU School of Public Health, Portland, United States","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA3691","last_page":"PA3691"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bronchiectasis","display_name":"bronchiectasis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/exacerbation-history","display_name":"exacerbation history","score":0.8050000071525574},{"id":"https://openalex.org/keywords/exacerbation-rate","display_name":"exacerbation frequency","score":0.875},{"id":"https://openalex.org/keywords/bronchiectasis-management","display_name":"bronchiectasis management","score":0.8190000057220459},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.7900000214576721},{"id":"https://openalex.org/keywords/nontuberculous-mycobacteria","display_name":"nontuberculous mycobacteria","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9397000074386597},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.866100013256073},{"id":"https://openalex.org/C2779379686","wikidata":"https://www.wikidata.org/wiki/Q32778","display_name":"Bronchiectasis","level":3,"score":0.8499000072479248},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.531499981880188},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.426800012588501},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40119999647140503},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3671000003814697},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.34380000829696655},{"id":"https://openalex.org/C2909082789","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma exacerbations","level":3,"score":0.33149999380111694},{"id":"https://openalex.org/C61470247","wikidata":"https://www.wikidata.org/wiki/Q7229825","display_name":"Population study","level":3,"score":0.30709999799728394},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2896000146865845},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.2870999872684479},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.28060001134872437},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2766999900341034},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.2736999988555908},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.26499998569488525},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.2646999955177307}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa3691","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3691","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa3691","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epidemiology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4312850621","https://openalex.org/W4410268548","https://openalex.org/W7154367016","https://openalex.org/W4312775280","https://openalex.org/W4416639322","https://openalex.org/W2889573530","https://openalex.org/W3004203260","https://openalex.org/W4367609462","https://openalex.org/W7203826549","https://openalex.org/W4376133757"],"abstract_inverted_index":{"Background:":[0],"Bronchiectasis":[1],"(BE)":[2],"clinical":[3,157,181],"guidelines":[4],"aim":[5],"to":[6,31,50],"control":[7],"symptoms,":[8],"reduce":[9],"exacerbation":[10,26,61,132],"and":[11,81,96],"prevent":[12],"disease":[13],"progression.":[14],"However,":[15,159],"it":[16],"is":[17],"unclear":[18],"whether":[19],"current":[20],"treatment":[21,33],"approaches":[22],"differ":[23],"based":[24],"on":[25,117],"history.":[27],"This":[28],"study":[29,68],"aimed":[30],"describe":[32],"in":[34],"adults":[35],"with":[36,73,104,111,156,165,170],"BE":[37],"using":[38],"the":[39,82,90],"US":[40],"BRR.":[41],"Method:":[42],"BRR":[43],"baseline":[44,60],"data":[45],"collected":[46],"2":[47],"years":[48],"prior":[49],"enrolment":[51],"were":[52,57,84,115,167],"retrospectively":[53],"analyzed.":[54],"Treatment":[55,103],"patterns":[56],"described":[58],"by":[59],"frequency":[62],"(BEF)":[63],"(Table":[64],"1).":[65],"Results:":[66],"The":[67,75,134],"population":[69],"included":[70],"6,182":[71],"patients":[72,88,114,125,164],"BE.":[74],"median":[76],"age":[77],"was":[78,153],"69":[79],"years,":[80],"majority":[83],"female":[85],"(79.1%).":[86],"Most":[87,113],"reported":[89],"use":[91,135],"of":[92,101,124,136,163],"bronchial":[93],"hygiene":[94],"therapy":[95],"mucous":[97],"active":[98],"agents":[99],"irrespective":[100],"BEF.":[102,112],"all":[105,143],"therapies":[106],"for":[107,131,148],"airway":[108],"inflammation":[109],"increased":[110],"not":[116,127,168],"maintenance":[118],"antibiotic":[119],"(ABX)":[120],"therapy.":[121],"Nearly":[122],"45%":[123],"did":[126],"receive":[128],"any":[129,137],"ABX":[130,138],"treatment.":[133],"remained":[139],"roughly":[140],"similar":[141],"across":[142],"BEF":[144],"among":[145],"those":[146],"treated":[147,169],"exacerbation.":[149],"Conclusions:":[150],"Clinical":[151],"practice":[152],"generally":[154],"consistent":[155],"guidelines.":[158],"a":[160],"large":[161],"number":[162],"exacerbations":[166],"ABX.":[171],"Future":[172],"studies":[173],"evaluating":[174],"symptomatology":[175],"may":[176],"identify":[177],"additional":[178],"factors":[179],"influencing":[180],"practice.":[182],"erj;66/suppl_69/PA3691/F1":[183],"F1":[184,185]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4416638352","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-11-25T00:00:00"}
